Drug Dosing in the Elderly Patients with Chronic Kidney Disease

Clinics in Geriatric Medicine

Volumn 25, Issue 3, 2009, Pages 459-527

  Olyaei, Ali J ^a   Bennett, William M ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b LEGACY GOOD SAMARITAN HOSPITAL   (United States)

Author keywords

Drug dosing; Kidney disease; Therapeutic drug monitoring; Toxicity

Indexed keywords

ACICLOVIR; ADEFOVIR DIPIVOXIL; AMIKACIN; AMINOPHYLLINE; CARBAMAZEPINE; CIDOFOVIR; CREATININE; CYCLOSPORIN; DIGOXIN; FOSCARNET; GENTAMICIN; INDINAVIR; INTERFERON; LIDOCAINE; LITHIUM; NEOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENOBARBITAL; PHENYTOIN; PROCAINAMIDE; QUINIDINE; RAPAMYCIN; STREPTOMYCIN; TACROLIMUS; TENOFOVIR; THEOPHYLLINE; TOBRAMYCIN; UNINDEXED DRUG; VALPROIC ACID; VANCOMYCIN;

ACUTE KIDNEY FAILURE; AGED; CHRONIC KIDNEY DISEASE; CONTINUOUS HEMODIAFILTRATION; CONTINUOUS HEMODIALYSIS; CONTINUOUS HEMOFILTRATION; CREATININE CLEARANCE; DIABETES INSIPIDUS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; ELDERLY CARE; FIBROSING ALVEOLITIS; GLOMERULUS FILTRATION RATE; GLUCOSURIA; HEMODIALYSIS; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPHOSPHATEMIA; INSOMNIA; INTERSTITIAL NEPHRITIS; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY ISCHEMIA; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ACIDOSIS; MEDICAL ASSESSMENT; MEDICATION ERROR; NEPHROLITHIASIS; NEPHROTIC SYNDROME; NEUROLOGIC DISEASE; NYSTAGMUS; PERITONEAL DIALYSIS; PRESCRIPTION; PREVALENCE; PROTEINURIA; REVIEW; RISK ASSESSMENT; TUBERCULOSIS; UNITED STATES;

AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DOSAGE CALCULATIONS; DRUG MONITORING; HUMANS; KIDNEY FAILURE, CHRONIC; PRESCRIPTION DRUGS;

EID: 70149096523     PISSN: 07490690     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cger.2009.04.004     Document Type: Review

References (54)

1. Hossain M.P., Goyder E.C., Rigby J.E., et al. CKD and poverty: a growing global challenge. Am J Kidney Dis 53 1 (2009) 166-174
2. Abdelhafiz A.H., Tan E., and El Nahas M. The epidemic challenge of chronic kidney disease in older patients. Postgrad Med 120 4 (2008) 87-94
3. Culberson J.W., and Ziska M. Prescription drug misuse/abuse in the elderly. Geriatrics 63 9 (2008) 22-31
4. Le Couteur D.G., and Kendig H. Pharmaco-epistemology for the prescribing geriatrician. Aust J Ageing 27 1 (2008) 3-7
5. Pannu N., and Nadim M.K. An overview of drug-induced acute kidney injury. Crit Care Med 36 4 Suppl (2008) S216-S223
6. Venkataraman R. Can we prevent acute kidney injury?. Crit Care Med 36 4 Suppl (2008) S166-S171
7. Manley H.J., Drayer D.K., and Muther R.S. Medication-related problem type and appearance rate in ambulatory hemodialysis patients. BMC Nephrol 4 (2003) 10-16
8. Ladriere M. [What is the best immunosuppression for the elderly kidney transplantation patient?]. Nephrol Ther 3 4 Suppl (2008) S179-S183 [in French]
9. Molony S.L. Monitoring medication use in older adults. Am J Nurs 109 1 (2009) 68-78
10. Pollock B., Forsyth C., and Bies R. The critical role of clinical pharmacology in geriatric psychopharmacology. Clin Pharmacol Ther 85 1 (2009) 89-93
11. Bond C.A., and Raehl C.L. Adverse drug reactions in United States hospitals. Pharmacotherapy 26 5 (2006) 601-608
12. Miller S.W. Evaluating medication regimens in the elderly. Consult Pharm 23 7 (2008) 538-547
13. Messinger-Rapport B.J., Thomas D.R., Gammack J.K., et al. Clinical update on nursing home medicine: 2008. J Am Med Dir Assoc 9 7 (2008) 460-475
14. McLean A.J., and Le Couteur D.G. Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56 2 (2004) 163-184
15. Aronow W.S. Treatment of hypertension in the elderly. Compr Ther 34 3-4 (2008) 171-176
16. Divakaran V.G., and Murugan A.T. Polypharmacy: an undervalued component of complexity in the care of elderly patients. Eur J Intern Med 19 3 (2008) 225-226
17. Ferrario C.G. Geropharmacology: a primer for advanced practice acute care and critical care nurses, part I. AACN Adv Crit Care 19 1 (2008) 23-35
18. Cantu T.G., Ellerbeck E.F., Yun S.W., et al. Drug prescribing for patients with changing renal function. Am J Hosp Pharm 49 12 (1992) 2944-2948
19. Ferrario C.G. Geropharmacology: a primer for advanced practice. Acute care and critical care nurses, part II. AACN Adv Crit Care 19 2 (2008) 134-149
20. Jain V., and Pitchumoni C.S. Gastrointestinal side effects of prescription medications in the older adult. J Clin Gastroenterol 43 (2009) 103-110
21. Sitar D.S. Aging issues in drug disposition and efficacy. Proc West Pharmacol Soc 50 (2007) 16-20
22. Diamond A.M., and Blum A.S. Epilepsy in the elderly. Med Health R I 91 5 (2008) 138-139
23. Bushardt R.L., Massey E.B., Simpson T.W., et al. Polypharmacy: misleading, but manageable. Clin Interv Aging 3 2 (2008) 383-389
24. Turnheim K. Pharmacokinetic dosage guidelines for elderly subjects. Expert Opin Drug Metab Toxicol 1 1 (2005) 33-48
25. Turnheim K. Drug therapy in the elderly. Exp Gerontol 39 11-12 (2004) 1731-1738
26. Turnheim K. When drug therapy gets old: pharmacokinetics and pharmacodynamics in the elderly. Exp Gerontol 38 8 (2003) 843-853
27. Thatte L., and Vaamonde C.A. Drug-induced nephrotoxicity: the crucial role of risk factors. Postgrad Med 100 6 (1996) 83-88 91
28. Appel G.B. Aminoglycoside nephrotoxicity. Am J Med 88 3C (1990) 16S-20S
29. Vanholder R., De Smet R., and Ringoir S. Factors influencing drug protein binding in patients with end stage renal failure. Eur J Clin Pharmacol 1 Suppl 44 (1993) S17-S21
30. Cherry K.E., and Morton M.R. Drug sensitivity in older adults: the role of physiologic and pharmacokinetic factors. Int J Aging Hum Dev 28 3 (1989) 159-174
31. von Winckelmann S.L., Spriet I., and Willems L. Therapeutic drug monitoring of phenytoin in critically ill patients. Pharmacotherapy 28 11 (2008) 1391-1400
32. Richens A. Clinical pharmacokinetics of phenytoin. Clin Pharmacokinet 4 3 (1979) 153-169
33. Barraclough K.A., Staatz C.E., Isbel N.M., et al. Therapeutic monitoring of mycophenolate in transplantation: is it justified?. Curr Drug Metab 10 2 (2009) 179-187
34. Perucca E. Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring. Ther Drug Monit 2 4 (1980) 331-344
35. Raehl C.L., Patel A.K., and LeRoy M. Drug-induced torsade de pointes. Clin Pharm 4 6 (1985) 675-690
36. Wynne H. Drug metabolism and ageing. J Br Menopause Soc 11 2 (2005) 51-56
37. Nolin T.D. Altered nonrenal drug clearance in ESRD. Curr Opin Nephrol Hypertens 17 6 (2008) 555-559
38. Dreisbach A.W., and Lertora J.J. The effect of chronic renal failure on drug metabolism and transport. Expert Opin Drug Metab Toxicol 4 8 (2008) 1065-1074
39. Nivoix Y., Leveque D., Herbrecht R., et al. The enzymatic basis of drug-drug interactions with systemic triazole antifungals. Clin Pharmacokinet 47 12 (2008) 779-792
40. Li Y.D., Davis G., and Lewis D. General principles of warfarin interactions in orthopedic patients. Orthopedics 31 10 (2008) pii
41. Freeman W.D., and Aguilar M.I. Management of warfarin-related intracerebral hemorrhage. Expert Rev Neurother 8 2 (2008) 271-290
42. Prigent A. Monitoring renal function and limitations of renal function tests. Semin Nucl Med 38 1 (2008) 32-46
43. Schmitt R., Coca S., Kanbay M., et al. Recovery of kidney function after acute kidney injury in the elderly: a systematic review and meta-analysis. Am J Kidney Dis 52 2 (2008) 262-271
44. Tedla F.M., and Friedman E.A. The trend toward geriatric nephrology. Prim Care 35 3 (2008) 515-530 vii
45. Cholongitas E., Shusang V., Marelli L., et al. Review article: renal function assessment in cirrhosis - difficulties and alternative measurements. Aliment Pharmacol Ther 26 7 (2007) 969-978
46. Winston J.A. Assessing kidney function in HIV infection. AIDS Read 17 5 (2007) 257-261 264
47. Coresh J., and Stevens L.A. Kidney function estimating equations: where do we stand?. Curr Opin Nephrol Hypertens 15 3 (2006) 276-284
48. Olyaei A., deMattos A.M., and Bennett W.M. Drug usage in dialysis patients in Clinical Dialysis (2005), McGraw-Hill, NY p. 891-926
49. Bouman C.S. Antimicrobial dosing strategies in critically ill patients with acute kidney injury and high-dose continuous veno-venous hemofiltration. Curr Opin Crit Care 14 6 (2008) 654-659
50. Pittrow L., and Penk A. Dosage adjustment of fluconazole during continuous renal replacement therapy (CAVH, CVVH, CAVHD, CVVHD). Mycoses 42 1-2 (1999) 17-19
51. Foote E.F., Dreitlein W.B., Steward C.A., et al. Pharmacokinetics of vancomycin when administered during high flux hemodialysis. Clin Nephrol 50 1 (1998) 51-55
52. Joy M.S., Matzke G.R., Armstrong D.K., et al. A primer on continuous renal replacement therapy for critically ill patients. Ann Pharmacother 32 3 (1998) 362-375
53. Matzke G.R., and Frye R.F. Drug administration in patients with renal insufficiency. Minimising renal and extrarenal toxicity. Drug Saf 16 3 (1997) 205-231
54. Matzke G.R. Pharmacotherapeutic consequences of recent advances in hemodialysis therapy. Ann Pharmacother 28 4 (1994) 512-514